September 2, 2024

 

Expansion of Evonik's MetAMINO^® production in Singapore completed

 

The expansion of Evonik's MetAMINO^® (DL-methionine) production facilities in Singapore has been completed.

 

The MetAMINO^® production on Singapore's Jurong Island is again running at full capacity, after shutdowns in Q4 2023 and Q2 2024. The production capacity has been increased by 40,000 metric tons, bringing the total to 340,000 metric tons per year. The expansion was accomplished ahead of schedule, according to Evonik.

 

Linde, one of Evonik's partners on Jurong Island, has designed, constructed, and is operating a nine-megawatt alkaline electrolyzer plant, which is the largest of its kind ever installed in Singapore. The unit enables Evonik's efforts to use green hydrogen required for the MetAMINO^® production and reflects the company's commitment to sustainability and reducing its environmental impact.

 

"Our collaboration with Linde on the implementation of green hydrogen in our Singapore facilities is a testament to our commitment to sustainability. We work closely with our partners to build a more sustainable future," said Dr. Harald Schwager, deputy chairman of Evonik's executive board.

 

Evonik's DL-methionine plants in Singapore have reduced the product carbon footprint of MetAMINO® at this site (Scope 1+2+3) by 6% compared to before the expansion.

 

The expansion of the MetAMINO^® production facilities was inaugurated during a festive ceremony attended by Grace Fu, Singapore's Minister for Sustainability and the Environment and Minister-in-Charge of Trade Relations.

 

"Evonik's latest expansion will help address two urgent problems – climate change and food production – in a sustainable way," Fu said. "By increasing its product yield with fewer emissions, Evonik's facility will help to feed a growing population while streamlining our carbon footprint. Congratulations to Evonik for paving the way to a more sustainable future."

 

In 2023, Evonik set its own science-based targets that have been approved by the Science Based Targets Initiative (SBTi) as consistent with a well-below 2°C (WB2C) pathway.

 

"We are committed to reducing emissions in line with the latest climate science, and consequently, we have a long-term ambition to expand our targets to align with a 1.5°C warming pathway and reach net-zero emissions by 2050", said Gaetano Blanda, head of Evonik's Animal Nutrition business line.

 

MetAMINO^® is used in livestock production to feed animals healthily, efficiently, and sustainably.

 

With its science-based approach, the Animal Nutrition business line of Evonik develops products, services and system solutions that help supply a growing world population with healthy, high-quality, and affordable animal protein.

 

The Animal Nutrition business is part of Evonik's Nutrition & Care division and contributes significantly to the profitable growth of Nutrition & Care through its self-financing power.

 

- Evonik